In both treatments, the upregulation of cardiac ACE2 could also be key to balancing RAS and preventing the deleterious effects of Angio II/AT1 on heart remodeling and programming of cardiomyopathy in this model of neonatal stress. This evidence concerns the gene ACE2 and cardiomyopathy.